SCHEMBL4983126

SCHEMBL4983126

Cc1nc(-c2cc(C(C)C)ccc2C(C)C)cs1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.41
▸ RECQL P46063 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ESR2 Q92731 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ NPC1 O15118 3/20 0.38
▸ RAB9A P51151 3/20 0.38
▸ HTT P42858 1/20 0.37
▸ MIF P14174 1/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ SCN4A P35499 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ TRPA1 O75762 1/20 0.36
▸ PTGS1 P23219 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7970526 0.75 GAA (0.57) RECQLGAAALDH1A1KDM4EMAPT
SCHEMBL20928591 0.74 HTT (0.39) RECQLGAAALDH1A1KDM4EMAPT
SCHEMBL14041787 0.73 RECQL (0.62) LMNARECQLGAAALDH1A1KDM4E
SCHEMBL20928933 0.70 MAPT (0.35) LMNARECQLALDH1A1MAPTHPGD
SCHEMBL19002850 0.68 MEN1 (0.56) RECQLGAAALDH1A1KDM4EMAPT
SCHEMBL8221631 0.68 GAA (0.53) RECQLGAAALDH1A1KDM4EMAPT
Iodide SCHEMBL4985813 0.67 LMNA (0.39) LMNATRPA1PTGS1CACNA1C
SCHEMBL24359598 0.66 GAA (0.52) RECQLGAAALDH1A1KDM4EMAPT
SCHEMBL27842459 0.66 LMNA (0.48) LMNAGAAALDH1A1KDM4EMAPT
SCHEMBL4986618 0.66 KDM4E (0.42) RECQLGAAALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080009416-A1 THIAZOLIUM COMPOUNDS AND USES THEREOF MYCOSOL, INC. 2008-01-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009416-A1 THIAZOLIUM COMPOUNDS AND USES THEREOF TST, TYR, THOP1 LMNA 4854/4885RECQL 4062/4885GAA 442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback